What’s New?

January 28, 2022

Video

Acne patients are benefitting from a robust pipeline with treatments that hold promise for increased efficacy and safety. First-in-class additions to the FDA-approved armamentarium, such as the novel antiandrogen clascoterone (Winlevi; Sun Pharma), give dermatologists and pediatricians new tools to combat this skin condition. Speakers offer insights on matching medications to individual patient needs and controlling costs.

EP: 1.Meet the Experts

EP: 2.Patient Assessment: Get the Patient’s History, Then Get Their Story

EP: 3.Tackling Tough Issues: How to Talk to Patients and Their Families

EP: 4.Next-level Diagnosis and Compliance

EP: 5.Acne’s Unseen Pain

Now Viewing